CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Gruber James R. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +38,621 | 38,621 | ||
| 2025-01-03 | Gruber James R. Chief Financial Officer | Grant or award · Restricted Stock Units | +25,876 | 25,876 | ||
| 2024-10-23 | Opaleye Management Inc. 10% owner | Purchase | +10,000 | $7.98 | $80K | 2,770,000 |
| 2024-10-08 | Opaleye Management Inc. 10% owner | Purchase | +30,000 | $7.03 | $211K | 2,760,000 |
| 2024-10-08 | Opaleye Management Inc. 10% owner | Purchase | +3,970 | $7.03 | $28K | 82,070 |
| 2024-10-07 | Opaleye Management Inc. 10% owner | Purchase | +10,000 | $7.22 | $72K | 2,730,000 |
| 2024-10-07 | Opaleye Management Inc. 10% owner | Purchase | +1,248 | $7.22 | $9K | 78,100 |
| 2024-10-04 | Opaleye Management Inc. 10% owner | Purchase | +15,000 | $6.77 | $102K | 2,720,000 |
| 2024-10-04 | Opaleye Management Inc. 10% owner | Purchase | +1,852 | $6.77 | $13K | 76,852 |
| 2024-10-02 | Krempa David Chief Business Officer | Grant or award · Restricted Stock Units | +42,088 | 861,374 | ||
| 2024-09-11 | Opaleye Management Inc. 10% owner | Purchase | +45,000 | $4.75 | $214K | 2,705,000 |
| 2024-09-11 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $4.75 | $24K | 75,000 |
| 2024-09-10 | Opaleye Management Inc. 10% owner | Purchase | +50,000 | $4.65 | $233K | 2,660,000 |
| 2024-09-10 | Opaleye Management Inc. 10% owner | Purchase | +7,500 | $4.65 | $35K | 70,000 |
| 2024-02-13 | Gruber James R. Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +144,677 | 374,763 | ||
| 2024-02-13 | Adams Jennifer McKie Director | Grant or award · Stock Option (Right to buy) | +30,000 | 133,133 | ||
| 2024-02-13 | BRYNJELSEN SEAN President & CEO | Grant or award · Stock Option (Right to buy) | +438,633 | 2,473,014 | ||
| 2024-02-13 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (Right to buy) | +30,000 | 164,555 | ||
| 2024-02-13 | Krempa David Chief Business Officer | Grant or award · Stock Option (Right to buy) | +144,677 | 813,430 | ||
| 2024-02-13 | MAIER PAUL V Director | Grant or award · Stock Option (Right to buy) | +30,000 | 164,555 |
Page 8 of 13 · 249 trades